Comply w/NEW Substance Use Disorder Patient Record Regs
Presented by: Brian L. Tuttle
Description:
New federal regulations significantly limit your use and disclosure of patient information when there is a diagnosis of substance use disorder (SUD) anywhere in their medical record, regardless of why you are currently seeing the patient.
What You Need to Know:
The recently released Substance Use Disorder Patient Records Regulations (42 CFR Part 2) restrict you from releasing even the smallest detail about a patient with an SUD diagnosis — even pursuant to a court order — without meeting specific criteria first. And should you incorrectly disclose restricted SUD information, this new rule has increased fines as high as $2 million per violation.
This Final Rule, a dense 162 pages of legalese, will most certainly be a nightmare to untangle and correctly implement. It changes how and when you can disclose SUD data, modifies reporting requirements, and even alters the mechanism for violation enforcement. It’s simply too risky to implement this new rule without some expert advice.
What You’ll Learn:
Below are just a few of the plain-English strategies Brian will share so you can stay compliant with the new SUD rules and keep your patient data private:
- Implement new consent requirements for your SUD patients
- Avoid easy-to-make downstream redisclosure violations
- Comply with new enforcement changes to avoid massive penalties
- Identify portions of new SUD regulations that can benefit your practice
- Uncover compliant plan requirements to head off costly violations
- Discover how these changes will impact patient care — and what you can do about it
- Pin down when a court order does require you to release SUD records
Benefits for Attending:
Even an accidental use or disclosure of patient SUD data can cost you thousands. The good news is that by attending Brian online training, you’ll receive proven strategies to help you more successfully comply with these new federal regulations and avoid significant violation penalties.